Unknown

Dataset Information

A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers.


ABSTRACT:

Purpose

Until now, results evaluating the expression of PSMA in ovarian cancer were sparse and contradictory. The aim was to reinvestigate the feasibility of a PSMA targeted theranostic approach in epithelial ovarian cancers with data from the tumour bank of a referring cancer centre.

Materials and methods

The OvaRessources Biological Resources Center database was screened from January 2004 to December 2017 to seek patients referred for the initial management of a serous epithelial ovarian cancer and for whom peritoneal histological samples were available in the tumour bank. Immunodetection of PSMA was performed to assess its cellular and neovascular expression. Slides were controlled by a certified pathologist, recorded as tiled tiff images and processed to compute the prop

SUBMITTER: Aide N 

PROVIDER: S-EPMC7873152 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature